Brad Resnick
LinkedIn Copy
Hey Brad — similar path (IB → PE). been thinking a lot about origination in tech-enabled services and healthcare lately. would be good to connect.
Hey Brad, similar IB → PE path, though I was in London at CS & Greenhill not at Riverside in NYC like you. origination was always the same story for me — clear thesis, decent relationships, but no proprietary system of record tying anything together. the people, tools and ideas were never really connected. every deal sourced from scratch, nothing compounding over time. curious if that's still how most funds operate or if I'm behind the times? — Russ
Hey Brad, looks like we share a similar IB → PE background, though I was in London doing growth equity at Treis not in NYC doing lower mid-market buyouts like you. the pattern I keep seeing with most funds is weirdly consistent — strong thesis, solid network, but no proprietary system of record. the people, tools and ideas are never really connected, so every deal is virtually sourced from scratch. nothing compounds on itself. curious if that resonates or if you've built something different at Aeonic? — Russ
hey Brad — no worries if the timing's off. most funds I talk to have tried some version of building origination in-house — analyst pulling from Pitchbook or Grata, maybe using ChatGPT to help qualify, dumping it into a spreadsheet. each piece kind of works, but there's no system of record tying it together. the people, tools and ideas are all disconnected so everything ends up out of sync. been helping a few funds like Mentmore work through that. curious if you've run into the same thing at Aeonic? — Russ
totally get it if origination infrastructure isn't top of mind right now — especially with permanent capital you've got a lot of plates spinning across the portfolio. the funds I've seen crack it early just tend to compound deal flow in a way that's hard to replicate later. if it ever moves up the list, I'm easy to find. — Russ
Email Copy
Brad — We've been building custom deal sourcing systems for funds deploying into lower middle market service and healthcare businesses — similar enough to what Aeonic does with its permanent capital approach. also, incidentally, we share a similar-ish path — I spent time at Greenhill and then moved to the investing side at a growth equity fund in London doing direct deals into B2B service companies. figured it made sense to reach out. One of our clients, Backer Group, uses a bespoke system we built to source founder and owner-led service businesses, score them on acquisition fit and owner readiness, and run personalized outreach (email, LinkedIn, and letters) — all plugged into their CRM with live updates. They're a small team, so origination runs in the background while they focus on portfolio and closing. Given you're investing permanently in high-quality management teams, the sourcing piece probably matters a lot — finding the right owners early and building that relationship before a process kicks off. I wondered if you wanted to take a look under the hood of what we've built? might be relevant to how Aeonic sources, might not — no worries either way. fairly free this week and next, just let me know a time that suits. very best, Russell searchloop.ai linkedin.com/in/russellt23
Prospect Research
## PROSPECT INFORMATION: Name: Brad Resnick Title: Partner Fund: Aeonic Partners Background: PROSPECT SUMMARY: Brad Resnick CURRENT FOCUS Brad is a Partner at Aeonic Partners in the Greater New York City Area, a role he has held since January 2019. He focuses on investing permanent capital into lower middle market private companies to facilitate organic growth and strategic acquisitions. He also currently serves on the Board of Directors for Quality Biomedical, a technology-enabled equipment management provider for healthcare. BACKGROUND Brad has an extensive background in private equity and board governance spanning nearly two decades. He spent over 10 years at The Riverside Company as a Principal (2008–2018), where he focused on industry-leading companies valued under $150 million. His previous experience include serving as an Analyst at ComVest Investment Partners. He has significant board-level experience across various industries, including security (Pro-Vigil), government administration (SAFEbuilt), healthcare (Physician’s Pharmacy Alliance), and marketing software (Brandmuscle). He is an alumnus of Cornell University (2002–2006). KEY SKILLS His core expertise lies in Private Equity, Leveraged Buyouts (LBO), M&A execution, and Restructuring. He is highly skilled in Due Diligence, Divestitures, and providing strategic oversight for middle-market companies. POSTS On December 3, 2015, Brad shared an article titled "Riverside sells Brandmuscle" with the subtitle "pehub.com." While the post did not contain unique body text, it highlighted a major exit for his firm at the time and his involvement with the portfolio company where he served as a Board Member. Fund details: - Description: We are experienced private equity investors partnering with high-quality management teams to build value over decades, not years. Our capital is permanent so we are not constrained by defined a defined investment horizon and required exit events, enabling us to maintain a singular focus on building high-quality, sustainable businesses over the long-term. - Website: https://www.aeonicpartners.com - Location: New York, New York, United States - Lead qualification: Research: - Query: =Aeonic Partners Brad Resnick recent investments fund thesis - Answer: Brad Resnick co-founded Aeonic Partners, a private equity firm investing in lower middle-market businesses. Aeonic Partners focuses on long-term control and minority investments. Resnick previously worked at The Riverside Company and Comvest Partners.